Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan.
Am J Prev Med. 2019 Apr;56(4):586-590. doi: 10.1016/j.amepre.2018.10.026. Epub 2019 Feb 14.
Hearing loss is common and associated with poorer health and impeded communication. Little is known about the association between hearing loss and substance use disorders in the general population. The objective of this study was to assess substance use disorder prevalence among individuals with hearing loss, versus those without hearing loss, in a nationally representative sample of adults.
Two years (2015 and 2016) of National Survey on Drug Use and Health (unweighted N=86,186) were combined to compare substance use disorders among adults with and without self-reported hearing loss. Statistical analysis included descriptive frequencies, chi-square tests, and multiple logistic regressions. Analyses were performed in 2018.
Hearing loss prevalence across all age groups was 5.2%. Among younger age groups, after adjusting for sociodemographics, hearing loss was independently associated with an increased likelihood of experiencing a substance use disorder (ages 18-34 years, AOR=1.34, 95% CI=1.10, 1.64 vs 35-49 years, AOR=1.87, 95% CI=1.39, 2.53). Hearing loss was also associated with a greater likelihood of a prescription opioid use disorder (AOR=2.85, 95% CI=1.86, 4.39) in the group aged 18-34 years and, for the group aged 35-49 years, hearing loss increased the likelihood of both an alcohol use disorder (AOR=1.87, 95% CI=1.39, 2.53) and a prescription opioid use disorder (AOR=1.99, 95% CI=1.01, 3.91).
Hearing loss is independently associated with substance use disorders among those aged 49 years and younger; these associations are particularly pronounced for prescription opioid use disorders in the group aged 18-34 years. Given the concern of inappropriate use of prescription opioids, this information may have implications for healthcare providers' pain management for patients with hearing loss.
听力损失很常见，与健康状况较差和沟通障碍有关。在普通人群中，听力损失与物质使用障碍之间的关系知之甚少。本研究的目的是评估在具有全国代表性的成年人样本中，听力损失者与无听力损失者之间物质使用障碍的患病率。
将 2015 年和 2016 年两年的全国药物使用与健康调查（未经加权 n=86186）合并，以比较有和无自我报告听力损失的成年人之间的物质使用障碍。统计分析包括描述性频率、卡方检验和多因素逻辑回归。分析于 2018 年进行。
所有年龄组的听力损失患病率为 5.2%。在年轻年龄组中，在调整社会人口统计学因素后，听力损失与经历物质使用障碍的可能性增加独立相关（年龄 18-34 岁，AOR=1.34，95%CI=1.10，1.64 vs 35-49 岁，AOR=1.87，95%CI=1.39，2.53）。听力损失也与 18-34 岁年龄组中处方类阿片使用障碍的可能性更大相关（AOR=2.85，95%CI=1.86，4.39），而对于 35-49 岁年龄组，听力损失增加了酒精使用障碍（AOR=1.87，95%CI=1.39，2.53）和处方类阿片使用障碍（AOR=1.99，95%CI=1.01，3.91）的可能性。
听力损失与 49 岁及以下人群的物质使用障碍独立相关；这些关联在 18-34 岁年龄组中，特别是与处方类阿片使用障碍的关联更为明显。鉴于对处方类阿片药物不当使用的担忧，这些信息可能对医疗保健提供者为听力损失患者进行疼痛管理产生影响。
